- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02516852
Assessing the Effect of Sustainable Small-scale Egg Production on Maternal and Child Nutrition in Rural Zambia
Animal source foods (ASF), such as meat and eggs, are rich in nutrients critical for growth and development. Yet, for poor children in developing countries, ASF consumption is limited by cost, inadequate caregiver knowledge, and lack of local production and physical availability. The impact of HH- and village-level livestock interventions on household dietary diversity and nutritional status in resource-poor communities is not well established. The objective of this study is to test the effectiveness of local egg production intervention on maternal and child diets and child nutrition status.
This project takes place in the Luangwa Valley, Zambia in partnership with a local non-governmental organization, COMACO. Twenty communities will be assigned to the intervention, and 20 matched communities will be selected as controls. In each intervention community, an egg production facility will be built, owned, and operated by trained COMACO farmers.
Households (HHs) in each community will be sampled twice annually for 1 year pre-intervention (baseline) and 1 year post-intervention to assess dietary diversity and nutritional status. Data analysis will test for a change in these outcomes from baseline in each intervention community compared to the matched control community.
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
The objective of this study is to test the effectiveness of an intervention establishing local egg production on maternal and child diets and nutrition status. The investigators hypothesize that this intervention, combined with appropriate agricultural extension and nutrition education programs, will result in: 1) increased total household, maternal, and child consumption of eggs; 2) improved maternal and child dietary quality; and 3) improved infant/ young child nutritional status.
The investigators will test this hypothesis in the Luangwa Valley, Zambia in partnership with a local non-governmental organization, Community Markets for Conservation (COMACO). The forty study sites are located in four geographic clusters (Chiefdoms) in Eastern Province Zambia. These Chiefdoms are located in two districts: Mambwe (Mnkhanya, Jumbe, and Nsefu Chiefdoms) and Lundazi (Mwanya Chiefdom).
Twenty communities will be assigned to the intervention (egg production), and 20 matched communities will be selected as controls (no intervention). In each intervention community, an egg production facility will be built, each owned and operated by trained COMACO farmers, mostly women. Each group will be provided layer pullets at point-of-lay and layer mash. Facility owners will make all business decisions, retain all profits, and will be responsible for all upkeep costs.
In a repeated cross-sectional study design, indicators of food security, wealth, diet, nutritional status (anthropometrics), and health and wellbeing will be assessed in all egg-producing HHs and in women/child dyads (children aged 6-36 months) residing in the area surrounding each facility or central control point. Data will be collected twice annually for 1 year pre-intervention (baseline) and 1 year post-intervention.
The exposure of interest is living in an egg-producing community. In the primary analysis, the investigators will use hierarchical mixed effects modeling to analyze the effect of the program on each of the outcomes of interest (see Outcome Measures section for details).
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Eastern Province
-
Mfuwe, Eastern Province, Zambia
- COMACO
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- the HH dwelling is ≤1.5 km from the egg production facility or central control point;
- there is a child 6-36 months of age in the HH; and,
Additionally, all HHs that include a member of the egg production group will be enrolled in the study, regardless of whether or not they meet the above inclusion criteria.
Exclusion Criteria:
- the mother/primary caretaker or head of HH cannot converse with the field staff because of language;
- the mother/primary caretaker or head of HH is unable to give informed consent or complete an interview without assistance; or,
- the child is deformed, disabled, severely ill, or unable to cooperate for anthropometric measures.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Innblanding
|
Establishment and support of a community-owned and -operated egg production facility located at a central location in the community
|
Ingen inngripen: Styre
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in child height-for-age Z-score
Tidsramme: 6, 12, 18, and 24 months after intervention
|
Recumbent length for children < 24 months and standing height for those 24-36 months, with WHO Child Growth Standards as the reference population.
|
6, 12, 18, and 24 months after intervention
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in household egg consumption
Tidsramme: 6, 12, 18, and 24 months after intervention
|
7 day recall on total number of chicken or other eggs consumed in the household
|
6, 12, 18, and 24 months after intervention
|
Change in maternal egg consumption
Tidsramme: 6, 12, 18, and 24 months after intervention
|
6, 12, 18, and 24 months after intervention
|
|
Change in child egg consumption
Tidsramme: 6, 12, 18, and 24 months after intervention
|
6, 12, 18, and 24 months after intervention
|
|
Change in maternal dietary diversity
Tidsramme: 6, 12, 18, and 24 months after intervention
|
Measured by Women's Dietary Diversity Score, a 24 hour recall of all foods consumed, organized into 9 food groups
|
6, 12, 18, and 24 months after intervention
|
Change in child dietary diversity
Tidsramme: 6, 12, 18, and 24 months after intervention
|
6, 12, 18, and 24 months after intervention
|
|
Change in child stunting
Tidsramme: 6, 12, 18, and 24 months after intervention
|
Defined as having a height-for-age z-score < -2.0, with WHO Growth Standards as the reference population.
|
6, 12, 18, and 24 months after intervention
|
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in household food security
Tidsramme: 6, 12, 18, and 24 months after intervention
|
Measure by Household Food Insecurity Access Scale (HFIAS), Household Hunger Scale (HHS) and/or Months of inadequate household food provisioning (MIHFP)
|
6, 12, 18, and 24 months after intervention
|
Change in producer household and poultry incomes
Tidsramme: 6, 12, 18, and 24 months after intervention
|
6, 12, 18, and 24 months after intervention
|
|
Change in maternal physical and emotional health
Tidsramme: 6, 12, 18, and 24 months after intervention
|
Measured through a 6-item index adapted from RAND short form
|
6, 12, 18, and 24 months after intervention
|
Change in maternal nutritional status
Tidsramme: 6, 12, 18, and 24 months after intervention
|
Measured by mid-upper arm circumference and body mass index
|
6, 12, 18, and 24 months after intervention
|
Change in child weight-for-height Z-score
Tidsramme: 6, 12, 18, and 24 months after intervention
|
6, 12, 18, and 24 months after intervention
|
|
Change in child weight-for-age Z-score
Tidsramme: 6, 12, 18, and 24 months after intervention
|
6, 12, 18, and 24 months after intervention
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Alexander J Travis, VMD, PhD, Cornell University
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 1402004456
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Underernæring, barn
-
MedDay Pharmaceuticals SAEurofins OptimedAvsluttetFriske Frivillige | Nedsatt leverfunksjon av moderat Child Pugh-kategoriFrankrike, Ungarn
-
RenJi HospitalFullførtBlodplateantall/miltdiameterforhold | Child-Pugh-klassifiseringKina
-
Stanford UniversityNational Cancer Institute (NCI)AvsluttetTilbakevendende hepatocellulært karsinom | Child-Pugh klasse A | Child-Pugh klasse BForente stater, Japan
-
Jay ZuckermanFullførtUtviklingskoordinasjonsforstyrrelse | Utviklingsdyspraksi | Clumsy Child SyndromeIsrael
-
Ohio State University Comprehensive Cancer CenterVarian Medical SystemsFullførtChild-Pugh klasse A | Stadium IIIA Hepatocellulært karsinom | Stadium IIIB Hepatocellulært karsinom | Stage IIIC hepatocellulært karsinom | Stage IVA Hepatocellulært karsinom | Stadium IVB hepatocellulært karsinom | Child-Pugh klasse BForente stater
-
Centre Hospitalier Universitaire DijonFullførtChild-Pugh A Hepatocellulært karsinomFrankrike
-
Centre Hospitalier Universitaire DijonFullførtIkke-opererbart ikke-metastatisk hepatocellulært karsinom | Child A/B7 CirrhoseFrankrike
-
Roswell Park Cancer InstituteMerck Sharp & Dohme LLCAktiv, ikke rekrutterendeAvansert hepatocellulært karsinom hos voksne | Child-Pugh klasse A | Stadium III hepatocellulært karsinom | Stadium IIIA Hepatocellulært karsinom | Stadium IIIB Hepatocellulært karsinom | Stage IIIC hepatocellulært karsinom | Stadium IV hepatocellulært karsinom | Stage IVA Hepatocellulært karsinom | Stadium...Forente stater
-
AstraZenecaAvsluttetMagekreft | Avanserte solide maligniteter | Solid svulst | Child-Pugh A til B7 avansert hepatocellulært karsinom | EGFR og/eller ROS Mutant NSCLC | LungemetastasekarsinomKorea, Republikken
Kliniske studier på Egg production
-
University of British ColumbiaFullført
-
International Food Policy Research InstituteHelen Keller International; Foreign Affairs, Trade and Development, CanadaFullførtAnemi | VeksthemningBurkina Faso
-
Helen Keller InternationalMount Saint Vincent University; International Development Research Centre...Aktiv, ikke rekrutterendeHelseatferd | Ungdomsadferd | EkteskapsalderBangladesh
-
Ruhr University of BochumFullførtSunne fag | Kompleks regionalt smertesyndrom type I i øvre lem | Ensidig lemsmerter av annen opprinnelseTyskland
-
International Centre for Diarrhoeal Disease Research...FullførtProtein underernæringBangladesh
-
Pennington Biomedical Research CenterEgg Nutrition CenterFullført
-
Hugh A Sampson, MDNational Institute of Allergy and Infectious Diseases (NIAID); Consortium...Fullført
-
Universidad de AntioquiaInstituto Colombiano para el Desarrollo de la Ciencia y la Tecnología...Fullført
-
Washington University School of MedicineUniversity of California, Davis; RTI International; Universidad San Francisco... og andre samarbeidspartnereFullført
-
North-West University, South AfricaAktiv, ikke rekrutterendeLineær vekstSør-Afrika